Search results

The National Deuteration Facility is providing deuterated cholesterol, an essential ingredient in lipid nanoparticles for the delivery of vaccines using mRNA, to academic and industry partners.

New facility will greatly enhance Australia’s capability in stress engineering for industry

Research has revealed the Lapita cultural group interacted with the indigenous people of Papua New Guinea more than 3,000 years ago and set the stage for the peopling of the Pacific

The Australian Synchrotron is a source of powerful X-rays and infrared radiation that can be used for a wide range of scientific and technical purposes. Synchrotron X-rays are millions of times brighter than those produced by conventional X-ray machines in laboratories and hospitals.

Australia’s nuclear agency ANSTO is continuing to lead planning efforts to repatriate what is called a TN-81 cask of intermediate-level radioactive from the United Kingdom in 2022.

Beamtime Guide on the X-ray Fluorescence Microscopy beamline at the Australian Synchrotron.

Learn. Create. Innovate

Sample environment types that are available on the Powder Diffraction beamline.

Neutron Activation Analysis (NAA) is a highly sensitive method of quantitative elemental analysis. There is a wide range of potential applications for neutron irradiations.

Our experienced team of engineers, metallurgists, chemists and scientists have a proven track record of working with our clients in Australia and around the world to design and evaluate novel flowsheets and improve established processes.

ANSTO's Minerals team provides consultancy, process development and research services to the mining and minerals processing industries.

Collaborators used X-ray imaging to understand the fine detail of how a damaging fungal pathogen reduces leaf function and grain yield of wheat crops.

A summary of all the radiopharmaceuticals available through ANSTO.

A summary of all the radiochemicals available at ANSTO.

A summary of all the nuclear medicine accessories available at ANSTO.

Health Products pricing, effective from 1 October 2024.